Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS)
November 2012
You'll hear about Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS).
It's not a completely new drug.
It's the active metabolite of leflunomide (Arava, etc)...the immunomodulator used to slow progression of rheumatoid arthritis.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote